New and emerging drug therapies for the management of acute heart failure

Authors: Krum, H.; Liew, D.

Source: Internal Medicine Journal, Volume 33, Number 11, November 2003 , pp. 515-520(6)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Abstract

In recent times, there have been many developments in therapies for acute heart failure, in contrast to the preceding 20 years. These have been mainly fuelled by new and expanding knowledge about the pathophysiology of heart failure, which has allowed for insight into potential therapeutic strategies. This review will examine the key emerging therapies for acute heart failure, in light of available pathophysiological and clinical evidence. (Intern Med J 2003; 33: 515−520)

Keywords: acute heart failure; nesiritide; review; tezosentan; ­levosimendan

Document Type: Research Article

DOI: http://dx.doi.org/10.1046/j.1445-5994.2003.00483.x

Publication date: November 1, 2003

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page